A Metastização Cervical dos Cancros Cutâneos de Cabeça e Pescoço
Resumo
O cancro cutâneo é a neoplasia mais frequente de todas, com maior incidência na área de cabeça e pescoço, pela fotoexposição crónica. A estratificação do risco metastático linfático regional cervical tende a ser sistematizada de acordo com modelos de estadiamento tumoral, que são tendencialmente aceites no melanoma e carcinoma de células de Merkel, mas pouco consensuais no carcinoma espinocelular. Um dos focos de investigação é o risco de micrometástases em casos de tumores de estádio clínico e imagiológico N0, de que um modo geral varia entre 5% a 20% nos carcinomas espinocelulares, cerca de 20% nos melanomas e de 20 a 50% nos carcinomas de células de Merkel, dependendo de vários fatores de risco. A utilidade do gânglio sentinela e os protocolos de acompanhamento são também matéria de discussão.
Downloads
Referências
Iorio ML, Ter Louw RP, Kauffman CL, Davison SP. Evidence-
Based Medicine: facial skin malignancy. Plast Reconstr
Surg. 2013;132: 1631-43.
Porceddu S V., Veness MJ, Guminski A. Nonmelanoma
cutaneous head and neck cancer and merkel cell carcinoma:
Current concepts, advances, and controversies. J
Clin Oncol. 2015;33: 3338-45.
RORENO. Registo Oncológico Nacional 2010. In: Inst.
Port. Oncol. do Porto Fr. Gentil - EPE, Porto. [consultado
Jun 2016] Disponível em: http://www.roreno.com.pt/
images/stories/pdfs/ro_nacional_2010.pdf.
Morand GB, Madana J, Da Silva SD, Hier MP, Mlynarek
AM, Black MJ. Merkel cell carcinoma of the head and
neck: poorer prognosis than non-head and neck sites. J
Laryngol Otol. 2016;130: 393-7.
Schmalbach CE, Bradford CR. Is sentinel lymph node
biopsy the standard of care for cutaneous head and neck
melanoma? Laryngoscope. 2015;125: 153-60.
Larson DL, Larson JD. Head and neck melanoma. Clin
Plast Surg. 2010;37: 73-7.
Clark WH, From L, Bernardino E a, Clark H, Bernardino
E, Mihm MC. The histogenesis and biologic behavior of
primary human malignant melanomas of the skin. Cancer
Res. 1969;705-27.
Breslow A. Thickness, cross-sectional areas and depth of
invasion in the prognosis of cutaneous melanoma. Ann
Surg. 1970;172: 902-8.
Byers RM, Wolf PF, Ballantyne AJ. Rationale for elective
modified neck dissection. Head Neck Surg. 1988;10:
-7.
Kritikos N, Priftakis D, Stavrinides S, Kleanthous S, Sarafianou
E. Nuclear medicine techniques in Merkel cell carcinoma:
A case report and review of the literature. Oncol
Lett. 2015;10: 1610-6.
Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA,
Storm FK, et al. Technical details of intraoperative lymphatic
mapping for early stage melanoma. Arch Surg.
;127: 392-9.
Morton DL. Overview and update of the phase III Multicenter
Selective Lymphadenectomy Trials (MSLT-I and
MSLT-II) in melanoma. Clin Exp Metastasis. 2012;29:
-706.
O’Brien CJ, Petersen-Schafer K, Papadopoulos T, Malka
V. Evaluation of 107 therapeutic and elective parotidectomies
for cutaneous melanoma. Am J Surg. 1994;168:
-3.
Cochran AJ, Balda BR, Starz H, Bachter D, Krag DN,
Cruse CW, et al. The Augsburg consensus: Techniques
of lymphatic mapping, sentinel lymphadenectomy, and
completion lymphadenectomy in cutaneous malignancies.
Cancer. 2000;89: 236-41.
Strassen U, Hofauer B, Jacobi C, Knopf A. Management
of locoregional recurrence in cutaneous squamous cell
carcinoma of the head and neck. Eur Arch Oto-Rhino-
-Laryngology. 2017; 274:501-6.
Stratigos A, Garbe C, Lebbe C, Malvehy J, Del Marmol
V, Pehamberger H, et al. Diagnosis and treatment of invasive
squamous cell carcinoma of the skin: European
consensus-based interdisciplinary guideline. Eur J Cancer.
;51: 1989-2007.
Marrazzo G, Thorpe R, Condie D, Pinho MC, Srivastava
D. Clinical and Pathologic Factors Predictive of Positive
Radiologic Findings in High-Risk Cutaneous Squamous
Cell Carcinoma. Dermatol Surg. 2015;41: 1405-10.
Wiser I, Phd M, Scope Md A, Bsc DA, Zloczower Bscmed
E, Carmel NN, et al. Head and neck cutaneous squamous
cell carcinoma clinicopathological risk Factors according
to age and gender: a Population-based study. Isr
Med Assoc J. 2016;18:275-8.
Breuninger H, Brantsch K, Eigentler T, Häfner H-M. Comparison
and evaluation of the current staging of cutaneous
carcinomas. J Dtsch Dermatol Ges. 2012;10: 579-86.
Haisma MS, Plaat BE, Bijl HP, Roodenburg JL, Diercks GF,
Romeijn TR, et al. Multivariate analysis of potential risk
factors for lymph node metastasis in patients with cutaneous
squamous cell carcinoma of the head and neck. J
Am Acad Dermatol. 2016;75: 722-30.
Stadler R, Assaf C, Klemke C, Nashan D, Weichenthal M,
Dummer R, et al. Update guidelines dermatologic oncology.
J Dtsch Dermatol Ges. 2013;11: 1-45.
Farasat S, Yu SS, Neel VA, Nehal KS, Lardaro T, Mihm
MC, et al. A new American Joint Committee on Cancer
staging system for cutaneous squamous cell carcinoma:
Creation and rationale for inclusion of tumor (T) characteristics.
J Am Acad Dermatol. 2011;64: 1051-9.
Warner CL, Cockerell CJ. The New Seventh Edition
American Joint Committee on Cancer Staging of Cutaneous
Non-Melanoma Skin Cancer. Am J Clin Dermatol.
;12: 147-54.
Brantsch KD, Meisner C, Schönfisch B, Trilling B, Wehner-
-Caroli J, Röcken M et al. Analysis of risk factors determining
prognosis of cutaneous squamous-cell carcinoma:
a prospective study. Lancet Oncol. 2008;9: 713-20.
Jambusaria-Pahlajani A, Kanetsky PA, Karia PS, Hwang
W-T, Gelfand JM, Whalen FM, et al. Evaluation of AJCC
tumor staging for cutaneous squamous cell carcinoma
and a proposed alternative tumor staging system. JAMA
Dermatol. 2013;149: 402-10.
Vauterin TJ, Veness MJ, Morgan GJ, Poulsen MG, O’Brien
CJ. Patterns of lymph node spread of cutaneous squamous
cell carcinoma of the head and neck. Head Neck.
;28: 785-91.
Durham AB, Lowe L, Malloy KM, McHugh JB, Bradford
CR, Chubb H, et al. Sentinel lymph node biopsy for cutaneous
squamous cell carcinoma on the head and neck.
JAMA Otolaryngol Head Neck Surg. 2016;48109: 1-6.
Trotter SC, Sroa N, Winkelmann RR, Olencki T, Bechtel
M. A global review of melanoma follow-up guidelines. J
Clin Aesthet Dermatol. 2013;6: 18-26.
Serra-Arbeloa P, Rabines-Juárez ÁO, Álvarez-Ruiz MS,
Guillén-Grima F. Estudio descriptivo de costes en melanoma
cutáneo de diferentes estadios. Actas Dermosifiliogr.
(in press).
Madu MF, Wouters MW, van Akkooi AC. Sentinel node
biopsy in melanoma: Current controversies addressed.
Eur J Surg Oncol. 2017;43:517-33.
Teixeira V, Vieira R, Coutinho I, Cabral R, Andrade P, Julião
MJ, et al. Biopsia de gânglio sentinela em Portugal
– experiência de um centro de referência. Rev Soc Port
Dermatol Venereol. 2014;71: 477-85.
Lee DY, Huynh KT, Teng A, Lau BJ, Vitug S, Lee J-H, et al.
Predictors and survival impact of false-negative sentinel
nodes in melanoma. Ann Surg Oncol. 2015;1012-8.
Guggenheim M, Dummer R, Jung FJ, Mihic-Probst D,
Steinert H, Rousson V, et al. The influence of sentinel
lymph node tumour burden on additional lymph node
involvement and disease-free survival in cutaneous melanoma--
a retrospective analysis of 392 cases. Br J Cancer.
;98: 1922-8.
Sawh-Martinez R, Douglas S, Pavri S, Ariyan S, Narayan
D. Management of head and neck melanoma: results of
a national survey. Ann Plast Surg. 2014;73: S175-S177.
Nahabedian MY, Tufaro AP, Manson PN. Sentinel lymph
node biopsy for the T1 (thin) melanoma: is it necessary?
Ann Plast Surg. 2003;50: 601-6.
Dummer R, Siano M, Hunger R, Lindenblatt N, Braun R,
Michielin O, et al. The updated Swiss guidelines 2016
for the treatment and follow-up of cutaneous melanoma.
Swiss Med Wkly. 2016;1-9.
Lemos M, Vieira R, Brinca A, Figueiredo A. Biópsia do
gânglio sentinela em melanomas espessos: estudo clínico
retrospectivo num único centro. Rev Soc Port Dermatol
Venereol. 2016;74: 255-9.
Dummer R, Hauschild A, Lindenblatt N, Pentheroudakis
G, Keilholz U. Cutaneous melanoma: ESMO Clinical
Practice Guidelines for diagnosis, treatment and follow-
-up. Ann Oncol. 2015;26: v126-v132.
National Comprehensive Cancer Network Clinical Pratice
Guidelines in Oncology Merkel Cell Carcinoma. [consultado
Jun 2016] Disponível em: https://www.nccn.org/
professionals/physician_gls/pdf/mcc.pdf.
Green B, Godden D, Brennan PA. Malignant cutaneous
adnexal tumours of the head and neck: an update on
management. Br J Oral Maxillofac Surg. 2015;53: 485-
Gunaratne DA, Howle JR, Veness MJ. Sentinel lymph
node biopsy in Merkel cell carcinoma: a 15 year institutional
experience and statistical analysis of 721 reported
cases. Br J Dermatol. 2015;273-81.
Cabral R, Brinca A, Vieira R, Mariano A, Tellechea Ó,
Figueiredo A. Carcinoma de células de Merkel – revisão
de 7 casos. Rev Soc Port Dermatol Venereol. 2014;71:
-6.
Strom TJ, Caudell JJ, Harrison LB. Management of
BCC and SCC of the head and neck. Cancer Control.
;23: 220-7.
Todos os artigos desta revista são de acesso aberto sob a licença internacional Creative Commons Attribution-NonCommercial 4.0 (CC BY-NC 4.0).
